ThinkCyte
Hongo
About ThinkCyte
ThinkCyte provides single-cell analysis for research, diagnostics, and therapeutics with an integrated multidisciplinary approach.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $86.4M
- Funding stage: Late Stage Venture
- Last round: Series C (Aug 2024)
- Website: thinkcyte.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/thinkcyte-80061 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.